Light therapy for blood sugar control in type 2 diabetes
Part of Hormones & metabolism clinical trials.
This trial tests whether shining a special light on the body (called photobiomodulation) can help improve blood sugar control in people with type 2 diabetes. It may be a gentle addition to your current diabetes care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 30 and 70 years old.
- You must have been diagnosed with type 2 diabetes.
- Your recent A1C (average blood sugar over 3 months) should be between 6.5% and 10%.
- Your diabetes treatment (medication and lifestyle) must be stable for at least 3 months.
- You cannot have severe diabetes complications, be sensitive to light, or be pregnant or nursing.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new type of cell therapy called cfMSC for people with type 2 diabetes. The goal is to see if it can help control blood sugar better, possibly by helping the body use insulin more effectively.
This study tests a non-invasive treatment called biophoton therapy (using light energy) to see if it can help control blood sugar in people with type 2 diabetes. If you qualify, you would receive this therapy and the research team would monitor your progress.
This study tests whether light therapy can improve how cells make energy and reduce stress on the body, in both healthy people and people with type 1 diabetes. If you join, you may learn if this approach helps your body function better.
This study tests whether shining a special light on diabetic foot ulcers can help them heal faster. It aims to find out if the treatment is safe and effective.
This study tests a painless light treatment (photobiomodulation) to see if it can prevent foot ulcers in people with type 2 diabetes who are at risk. If you qualify, you would receive the treatment regularly and be monitored for foot health.
This study tests an experimental medicine called RGB-5088 for people with type 2 diabetes who are already using insulin. The goal is to see if it can safely improve blood sugar control when added to your current diabetes management.
Hear when a new Type II Diabetes Mellitus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.